×
Medicus Pharma Price to Free Cash Flow Ratio 1971-1970 | MDCX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Medicus Pharma price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
View More
Medicus Pharma Price to Free Cash Flow Ratio 1971-1970 | MDCX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Medicus Pharma price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$149.5B
Bristol Myers Squibb (BMY)
$121.6B
Vertex Pharmaceuticals (VRTX)
$119.9B
Gilead Sciences (GILD)
$117.2B
CSL (CSLLY)
$88.1B
Regeneron Pharmaceuticals (REGN)
$83.8B
GSK (GSK)
$71.1B
Argenex SE (ARGX)
$37.3B
Alnylam Pharmaceuticals (ALNY)
$32.6B
BioNTech SE (BNTX)
$28.1B
Biogen (BIIB)
$23.9B
Illumina (ILMN)
$23B
BeiGene (BGNE)
$20B
Moderna (MRNA)
$17B
Genmab (GMAB)
$14.5B
Incyte (INCY)
$14.1B
Insmed (INSM)
$13B
BioMarin Pharmaceutical (BMRN)
$12.4B
Sarepta Therapeutics (SRPT)
$12.2B
Bio-Techne Corp (TECH)
$12.1B
Exact Sciences (EXAS)
$11.4B
Vaxcyte (PCVX)
$11.4B
Exelixis (EXEL)
$10.2B
QIAGEN (QGEN)
$10B
Bio-Rad Laboratories (BIO.B)
$9.4B
Intra-Cellular Therapies (ITCI)
$9.1B
Roivant Sciences (ROIV)
$9.1B
Revolution Medicines (RVMD)
$8.7B
Repligen (RGEN)
$8.4B
Ascendis Pharma (ASND)
$8.1B